ESMO 2016: News Articles

Interested in what is happening during ESMO 2016? Read our news articles here

Date Title Topic
11 Oct 2016 Cabozantinib superior to sunitinib in phase II study of metastatic RCC Genitourinary cancers - Anticancer agents & Biologic therapy
11 Oct 2016 Selumetinib plus docetaxel fails to show significant benefits over docetaxel alone in KRAS-mutant NSCLC Lung and other thoracic tumours
11 Oct 2016 Custirsen: Disappointment so far despite a strong biological rationale Genitourinary cancers - Anticancer agents & Biologic therapy
11 Oct 2016 Immune checkpoint inhibitors for urothelial cancer: New hope with new options Genitourinary cancers - Anticancer agents & Biologic therapy
11 Oct 2016 ESMO and ASCO working together to take better care of our patients
11 Oct 2016 ESMO 2016: Daily Reporter Editorial Team highlights
11 Oct 2016 Advancing the treatment of sarcoma Sarcomas - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016: The NETwork! Translational Programme Facilitates Genomic Analysis of Neuroendocrine Tumours Translational research - Endocrine and neuroendocrine tumours
10 Oct 2016 ESMO 2016: Metformin Significantly Lowers the Risk of Cancer Progression in Patients with Diabetes and Advanced pNETs Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
10 Oct 2016 ESMO 2016: Clinical Benefit Demonstrated with Everolimus and Pasireotide LAR Alone or in Combination in the First Randomised, Prospective Study Entirely Dedicated to Advanced Lung and Thymic Carcinoids Endocrine and neuroendocrine tumours - Anticancer agents & Biologic therapy
10 Oct 2016 Controversy of the Day Biosimilars and bioequivalents: A wise choice in a demanding treatment landscape? Anticancer agents & Biologic therapy
10 Oct 2016 Precision medicine: Evolving trial design for targeted treatment Personalised medicine
10 Oct 2016 Female oncologists: Still paying the price for being a woman
10 Oct 2016 First-line immunotherapy for advanced NSCLC: A chink in nivolumab’s armour? Greater patient selection needed! Lung and other thoracic tumours
10 Oct 2016 ESMO 2016: Meta-Analysis Confirms Superiority of Concomitant Over Induction Chemotherapy in Non-Metastatic HNSCC Head and neck cancers